×
About 26,210 results

ALLMedicine™ Bipolar Disorder Center

Research & Reviews  8,633 results

Peripheral Levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and in...
https://doi.org/10.1016/j.bbi.2021.07.014
Brain, Behavior, and Immunity; Solmi M, Sharma MS et. al.

Aug 1st, 2021 - It is unclear whether differences exist in the magnitude and variability of pro-inflammatory mediators in the different phases of bipolar disorder (BD) and among subjects with BD, as compared to healthy controls. To run a comparative meta-analysis...

An epidemiological study of externally determined and self-identified mental and physic...
https://doi.org/10.1016/j.jad.2021.07.085
Journal of Affective Disorders; Scott J, Morton E et. al.

Aug 1st, 2021 - Studies exploring disability in bipolar disorder (BD) have primarily assessed clinical samples of full-threshold BD-I and BD-II alongside so-called objective criteria such as unemployment or receipt of government disability payments. This study ex...

Advancing health through research: A scoping review of and model for adjunctive psychos...
https://doi.org/10.1016/j.jad.2021.07.024
Journal of Affective Disorders; Friedman R, Giampaolo J et. al.

Aug 1st, 2021 - We aimed to identify randomized clinical trials (RCTs) which evaluated the efficacy of adjunctive psychosocial interventions to improve outcomes during the perinatal period for women with bipolar disorder (BD). We scanned the literature to identif...

The meaningful change threshold as measured by the 16-item quick inventory of depressiv...
https://doi.org/10.1016/j.jad.2021.07.035
Journal of Affective Disorders; McIntyre RS, Lipsitz O et. al.

Aug 1st, 2021 - .To identify a meaningful change threshold (MCT) in depression outcomes in adults with treatment-resistant major depressive disorder (MDD) or bipolar disorder (BD) receiving intravenous ketamine treatment at a community-based mood disorders center...

Identification of pleiotropy at the gene level between psychiatric disorders and relate...
https://doi.org/10.1038/s41398-021-01530-4 10.1038/nature13595 10.1038/mp.2014.188 10.1038/nn.4228 10.1038/ng.3285 10.1126/science.aap8757 10.1016/j.ajhg.2013.01.001 10.1371/journal.pgen.1003455 10.1093/schbul/sbt168 10.1038/s41588-017-0009-4 10.1038/ng.3406 10.1038/ng.2711 10.1016/j.jaac.2017.11.013 10.1093/humrep/15.7.1476 10.1111/j.1469-1809.2006.00310.x 10.1016/j.jcf.2008.03.009 10.1016/S1569-1993(11)60014-3 10.1086/301749 10.1155/2013/928562 10.1038/s41398-017-0033-2 10.1038/ng.2213 10.1093/schbul/sbn028 10.4103/0019-5545.31613 10.1016/j.psychres.2011.08.021 10.1038/nature17671 10.1038/s41467-018-04362-x 10.1038/ng.3869 10.1007/s11682-013-9269-5 10.1038/nature14101 10.1038/mp.2015.209 10.1161/STROKEAHA.118.020811 10.1038/nn.4228 10.1002/j.2051-5545.2011.tb00024.x 10.1017/S0033291701004044 10.1016/j.psychres.2004.09.002 10.1002/ajmg.b.32333 10.4081/mi.2013.e2 10.1038/s41598-017-02346-3 10.1038/mp.2012.21 10.1038/mp.2013.187 10.1038/mp.2010.107 10.1038/s41588-019-0397-8 10.1038/mp.2015.197 10.1038/ng.3552 10.1007/s10519-014-9654-x 10.1038/mp.2010.128 10.1038/npp.2016.197 10.1093/nar/gkj144 10.1016/j.ajhg.2012.02.025 10.1086/519795 10.2307/2529826 10.1002/gepi.20636 10.1093/bioinformatics/bth457 10.1093/schbul/sbx148 10.1038/nature15393 10.1192/bjp.158.4.471 10.1007/s11910-014-0499-8 10.1186/alzrt268 10.1371/journal.pone.0180356 10.1086/303070 10.1038/s41380-017-0001-5 10.1093/bioinformatics/bth457 10.1523/JNEUROSCI.5794-10.2011 10.1371/journal.pgen.1001308 10.1038/sj.jcbfm.9600419 10.1016/j.cell.2015.10.067 10.1038/s41588-018-0059-2 10.3389/fpsyt.2017.00083 10.1371/journal.pbio.1000579 10.1371/journal.pbio.1001008 10.1038/srep30805 10.1016/j.neuron.2015.11.025 10.1038/ng.3396 10.1038/nature19847 10.1056/NEJMoa1502214 10.1002/ajmg.b.32125 10.1038/nature02168 10.1093/bioinformatics/btq419 10.1016/j.jpsychires.2010.02.002
Translational Psychiatry; Polushina T, Banerjee N et. al.

Jul 31st, 2021 - Major mental disorders are highly prevalent and make a substantial contribution to the global disease burden. It is known that mental disorders share clinical characteristics, and genome-wide association studies (GWASs) have recently provided evid...

see more →

Guidelines  7 results

EPA guidance on physical activity as a treatment for severe mental illness: a meta-revi...
https://doi.org/10.1016/j.eurpsy.2018.07.004
European Psychiatry : the Journal of the Association of E... Stubbs B, Vancampfort D et. al.

Sep 28th, 2018 - Physical activity (PA) may be therapeutic for people with severe mental illness (SMI) who generally have low PA and experience numerous life style-related medical complications. We conducted a meta-review of PA interventions and their impact on he...

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947163
Bipolar Disorders; Yatham LN, Kennedy SH et. al.

Mar 15th, 2018 - The Canadian Network for Mood and Anxiety Treatments (CANMAT) previously published treatment guidelines for bipolar disorder in 2005, along with international commentaries and subsequent updates in 2007, 2009, and 2013. The last two updates were p...

Methodological recommendations for cognition trials in bipolar disorder by the Internat...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282834
Bipolar Disorders; Miskowiak KW, Burdick KE et. al.

Sep 13th, 2017 - To aid the development of treatment for cognitive impairment in bipolar disorder, the International Society for Bipolar Disorders (ISBD) convened a task force to create a consensus-based guidance paper for the methodology and design of cognition t...

The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendation...
https://www.ncbi.nlm.nih.gov/pubmed/22303521
Annals of Clinical Psychiatry : Official Journal of the A... Beaulieu S, Saury S et. al.

Feb 4th, 2012 - Mood disorders, especially bipolar disorder (BD), frequently are associated with substance use disorders (SUDs). There are well-designed trials for the treatment of SUDs in the absence of a comorbid condition. However, one cannot generalize these ...

see more →

Drugs  517 results see all →

Clinicaltrials.gov  418 results

A Study of Repetitive Transcranial Magnetic Stimulation in Bipolar Patients
https://clinicaltrials.gov/ct2/show/NCT03207048

Apr 27th, 2020 - Cognitive deficits are core features of bipolar disorder. Preliminary evidence shows that repetitive transcranial magnetic stimulation (rTMS) might have positive effects in enhancing cognition and improving clinical symptoms in patients with depre...

Lithium Effects on the Brain's Functional and Structural Connectome in the Treatment of Bipolar Disorder
https://clinicaltrials.gov/ct2/show/NCT03336918

Apr 22nd, 2020 - The premise of this proposal is that the clinical efficacy of lithium in bipolar disorder, and its complex effects on multiple brain physiological functions, may be best deciphered using a network properties-metric approach. This approach is criti...

Child & Adolescent Bipolar Disorder Brain Imaging and Treatment Study
https://clinicaltrials.gov/ct2/show/NCT00006177

Apr 21st, 2020 - Objective: For this protocol we define Bipolar Spectrum disorders (BSD) as the propensity to have a manic episode by having Bipolar Disorder or Substance/Medication-Induced Bipolar and Related Disorder. BSD in children and adolescents is receiving...

Evaluation of the Genetics of Bipolar Disorder
https://clinicaltrials.gov/ct2/show/NCT00001174

Apr 20th, 2020 - Bipolar affective disorder is a severe, heritable condition affecting about one percent of the population. The mode of inheritance is poorly understood and probably involves multiple loci of small to moderate effect. In this project, we use geneti...

Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder
https://clinicaltrials.gov/ct2/show/NCT00025935

Apr 20th, 2020 - Objective: Irritability is a common and impairing clinical presentation in youth (Collishaw et al 2010, Leibenluft 2011, Peterson et al 1996). Despite its significant public health impact, the clinical course and pathophysiology of irritability re...

see more →

News  882 results

A Community-Based Mental Health Program Pivots During the Pandemic
https://www.medscape.com/viewarticle/953393

Jun 18th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. For more than 70 years, Fountain House has offered a lifeline for people living with schizophrenia, bipolar disorder, major depression, and other ...

Emotional Support Animals Help Lick Symptoms of Depression, Anxiety in Serious Mental Illness
https://www.medscape.com/viewarticle/952310

Jun 2nd, 2021 - Use of emotional support animals (ESAs) yields quantifiable reductions in depression, anxiety, and loneliness for patients with serious mental illness (SMI) who live alone, early research suggests. Investigators followed 11 community-dwelling adul...

Fast Five Quiz: How Much Do You Know About Tardive Dyskinesia?
https://reference.medscape.com/viewarticle/910550

May 21st, 2021 - Tardive dyskinesia (TD) is a movement disorder caused by the use of dopaminergic antagonists or other antipsychotic medications. Patients with schizophrenia, schizoaffective disorder, or bipolar disorder who have a history of long-term use of dopa...

Trending Clinical Topic: Bipolar Disorder
https://reference.medscape.com/viewarticle/951265

May 21st, 2021 - Each week, we identify one top search term, speculate about what caused its popularity, and provide an infographic on a related condition. If you have thoughts about what's trending and why, share them with us on Twitter or Facebook. From the role...

Fast Five Quiz: How Much Do You Know About Tardive Dyskinesia?
https://www.medscape.com/viewarticle/910550

May 21st, 2021 - Tardive dyskinesia (TD) is a movement disorder caused by the use of dopaminergic antagonists or other antipsychotic medications. Patients with schizophrenia, schizoaffective disorder, or bipolar disorder who have a history of long-term use of dopa...

see more →

Patient Education  27 results see all →